Compare EPR Properties (EPR) vs Edwards Lifesciences Corporation Common Stock (EW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
EPR Properties vs Edwards Lifesciences Corporation Common Stock — how do they compare? EPR Properties trades at $54.87 (market cap $4.14B), while Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $49.44B). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 11.9× EPR Properties's market cap, and EPR Properties pays a 6.88% dividend while Edwards Lifesciences Corporation Common Stock pays none. Which is the better fit depends on your goals.
| EPR | EW | |
|---|---|---|
Market Cap | $4.14B | $49.44B |
Volume | 874,621 | 3,508,027 |
Sector | Real Estate | Health |
52-Week High | $64.32 | $95.18 |
52-Week Low | $48.71 | $72.65 |
Typical Hold Time | 45 Days | — |
Enterprise Value | $7.65B | $45.90B |
Dividend Yield | 6.88% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EPR Properties trades at $54.08, down 2.15% on the day, with a bearish technical signal. The REIT maintains strong fundamentals, including a 91.41% gross margin and a 37.66% net income margin, though net income is projected to dip slightly in 2026. Recent news highlights its focus on monthly dividends and diversification beyond theaters into experiential properties.
The outlook is mixed; analyst consensus is a 'Buy' with a $65.50 price target, suggesting significant upside, but technical indicators and a recent earnings miss signal near-term caution. Key risks include exposure to interest rate sensitivity and execution of its diversification strategy amidst a bearish market sentiment.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About EPR Properties
EPR Properties is a REIT specializing in experiential real estate, including movie theaters and leisure destinations like ski resorts and water parks across the US and Canada.
Read more on EPR →About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →
